Evidence map›Paper›PMID 42661062›Full record

ArticleEMBO reports2026

DNA end-resection is stimulated by an interaction between BRCA1 exon 11 and TOPBP1.

Marta San Martín Alonso, Rosalie A Kampen, Anne Schreuder, Daniel Salas, Arnoud H de Ru, Veronica Garzero, Romy L S Mesman, Román González-Prieto, Peter A van Veelen, Sylvie M Noordermeer

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marta San Martín AlonsoDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-9781-864X
Rosalie A KampenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0009-0004-2857-5153
Anne SchreuderDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Daniel SalasDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-7336-2887
Arnoud H de RuCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Veronica GarzeroDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Romy L S MesmanDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Román González-PrietoDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-8997-2321
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Sylvie M NoordermeerDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. s.m.noordermeer@lumc.nl.ORCID http://orcid.org/0000-0003-2737-9690

Funding

KWF Kankerbestrijding (KWF) 11367 / 2017-2Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 91116004NWO | Exacte en Natuurwetenschappen (ENW) VI.Vidi.192.039
6 · The paper itself

Abstract

Approximately 60% of the tumour suppressor protein BRCA1 is encoded by a single exon. Many tumours carry mutations in this exon, often resulting in exon skipping and thus a protein of a severely reduced size. Although none of the well-described protein domains of BRCA1 are encoded by this exon 11, the isoform lacking this part shows a hypomorphic activity in homologous recombination. To better understand the function of this large exon, we performed proteomic analyses to identify interaction partners via this part of the protein. Here, we report a DNA damage- and phospho-dependent interaction of TOPBP1 with the protein region of BRCA1 encoded by exon 11. Mechanistically, this interaction is required for BRCA1's role in end-resection during homologous recombination. In contrast, the interaction is not required for TOPBP1's role in ATR activation. Our data provide novel mechanistic insight into the function of this poorly characterized part of the BRCA1 protein.

Indexed as

BRCA1 ProteinCarrier ProteinsDNA-Binding ProteinsExonsNuclear ProteinsAtaxia Telangiectasia Mutated ProteinsDNA DamageHomologous RecombinationHumansProtein BindingAtaxia Telangiectasia Mutated ProteinsATR protein, humanBRCA1 ProteinBRCA1 protein, humanCarrier ProteinsDNA-Binding ProteinsNuclear ProteinsTOPBP1 protein, human

Identifiers

PMID42661062
PMCPMC13650151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.